PS
Prashant Somayaji Tangirala
About Prashant Somayaji Tangirala
Prashant Somayaji Tangirala has 4 years in corporate governance. Holds Additional Director and Designated Partner roles. Currently with 2 companies, including Prothree Packaging Solutions Private Limited and Neocell Bio-Technologies Llp. Formerly with 1 company. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Prothree Packaging Solutions Private Limited
U20210PN2020PTC193232
|
Additional Director | 13 Jul 2022 | 2020 | Active |
Neocell Bio-Technologies Private Limited
U21001TS2023PTC179295
|
Director | 23 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Neocell Bio-Technologies Llp
ABZ-3101
|
Designated Partner | 05 Dec 2022 | 2022 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prashant Somayaji Tangirala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prashant Somayaji Tangirala
Prashant Somayaji Tangirala has 4 years in corporate governance. Holds Additional Director and Designated Partner roles. Currently with 2 companies, including Prothree Packaging Solutions Private Limited and Neocell Bio-Technologies Llp. Formerly with 1 company. Engaged in General Business, Technology. Contributes to corporate operations.
Prashant Somayaji Tangirala is associated with 2 companies as Additional Director and Designated Partner.
Prashant Somayaji Tangirala has expertise in General Business, Technology.
Prashant Somayaji Tangirala has 4 years in corporate governance.